Thibault C, Bennamoun M, Flechon A, Gravis G, et al. Neoadjuvant Durvalumab +/- Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study. J Clin Oncol 2026;44:1921-1932.
PMID: 42190158